Literature DB >> 25670854

Regulation of GATA-binding protein 2 levels via ubiquitin-dependent degradation by Fbw7: involvement of cyclin B-cyclin-dependent kinase 1-mediated phosphorylation of THR176 in GATA-binding protein 2.

Tomomi Nakajima1, Kyoko Kitagawa2, Tatsuya Ohhata2, Satoshi Sakai2, Chiharu Uchida3, Kiyoshi Shibata3, Naoko Minegishi4, Kanae Yumimoto5, Keiichi I Nakayama5, Kazuma Masumoto6, Fuminori Katou6, Hiroyuki Niida2, Masatoshi Kitagawa7.   

Abstract

A GATA family transcription factor, GATA-binding protein 2 (GATA2), participates in cell growth and differentiation of various cells, such as hematopoietic stem cells. Although its expression level is controlled by transcriptional induction and proteolytic degradation, the responsible E3 ligase has not been identified. Here, we demonstrate that F-box/WD repeat-containing protein 7 (Fbw7/Fbxw7), a component of Skp1, Cullin 1, F-box-containing complex (SCF)-type E3 ligase, is an E3 ligase for GATA2. GATA2 contains a cell division control protein 4 (Cdc4) phosphodegron (CPD), a consensus motif for ubiquitylation by Fbw7, which includes Thr(176). Ectopic expression of Fbw7 destabilized GATA2 and promoted its proteasomal degradation. Substitution of threonine 176 to alanine in GATA2 inhibited binding with Fbw7, and the ubiquitylation and degradation of GATA2 by Fbw7 was suppressed. The CPD kinase, which mediates the phosphorylation of Thr(176), was cyclin B-cyclin-dependent kinase 1 (CDK1). Moreover, depletion of endogenous Fbw7 stabilized endogenous GATA2 in K562 cells. Conditional Fbw7 depletion in mice increased GATA2 levels in hematopoietic stem cells and myeloid progenitors at the early stage. Increased GATA2 levels in Fbw7-conditional knock-out mice were correlated with a decrease in a c-Kit high expressing population of myeloid progenitor cells. Our results suggest that Fbw7 is a bona fide E3 ubiquitin ligase for GATA2 in vivo.
© 2015 by The American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Keywords:  Cyclin-dependent Kinase (CDK); Fbw7; GATA Transcription Factor; Phosphorylation; Protein Degradation; Ubiquitin Ligase; Ubiquitylation (Ubiquitination)

Mesh:

Substances:

Year:  2015        PMID: 25670854      PMCID: PMC4400347          DOI: 10.1074/jbc.M114.613018

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  54 in total

1.  Phosphorylation-dependent degradation of c-Myc is mediated by the F-box protein Fbw7.

Authors:  Masayoshi Yada; Shigetsugu Hatakeyama; Takumi Kamura; Masaaki Nishiyama; Ryosuke Tsunematsu; Hiroyuki Imaki; Noriko Ishida; Fumihiko Okumura; Keiko Nakayama; Keiichi I Nakayama
Journal:  EMBO J       Date:  2004-04-22       Impact factor: 11.598

2.  Comprehensive identification of substrates for F-box proteins by differential proteomics analysis.

Authors:  Kanae Yumimoto; Masaki Matsumoto; Koji Oyamada; Toshiro Moroishi; Keiichi I Nakayama
Journal:  J Proteome Res       Date:  2012-05-01       Impact factor: 4.466

Review 3.  The ubiquitin system.

Authors:  A Hershko; A Ciechanover
Journal:  Annu Rev Biochem       Date:  1998       Impact factor: 23.643

4.  GATA-2 anomaly and clinical phenotype of a sporadic case of lymphedema, dendritic cell, monocyte, B- and NK-cell (DCML) deficiency, and myelodysplasia.

Authors:  Hiroyuki Ishida; Kosuke Imai; Kenichi Honma; Shin-Ichi Tamura; Toshihiko Imamura; Masafumi Ito; Shigeaki Nonoyama
Journal:  Eur J Pediatr       Date:  2012-03-21       Impact factor: 3.183

5.  A cyclin-dependent kinase inhibitor, butyrolactone I, inhibits phosphorylation of RB protein and cell cycle progression.

Authors:  M Kitagawa; H Higashi; I S Takahashi; T Okabe; H Ogino; Y Taya; S Hishimura; A Okuyama
Journal:  Oncogene       Date:  1994-09       Impact factor: 9.867

6.  Targeted disruption of Skp2 results in accumulation of cyclin E and p27(Kip1), polyploidy and centrosome overduplication.

Authors:  K Nakayama; H Nagahama; Y A Minamishima; M Matsumoto; I Nakamichi; K Kitagawa; M Shirane; R Tsunematsu; T Tsukiyama; N Ishida; M Kitagawa; K Nakayama; S Hatakeyama
Journal:  EMBO J       Date:  2000-05-02       Impact factor: 11.598

Review 7.  Emerging roles of the FBW7 tumour suppressor in stem cell differentiation.

Authors:  Zhiwei Wang; Hiroyuki Inuzuka; Hidefumi Fukushima; Lixin Wan; Daming Gao; Shavali Shaik; Fazlul H Sarkar; Wenyi Wei
Journal:  EMBO Rep       Date:  2011-12-23       Impact factor: 8.807

8.  Control of lipid metabolism by phosphorylation-dependent degradation of the SREBP family of transcription factors by SCF(Fbw7).

Authors:  Anders Sundqvist; Maria T Bengoechea-Alonso; Xin Ye; Vasyl Lukiyanchuk; Jianping Jin; J Wade Harper; Johan Ericsson
Journal:  Cell Metab       Date:  2005-06       Impact factor: 27.287

9.  Perifosine inhibits mammalian target of rapamycin signaling through facilitating degradation of major components in the mTOR axis and induces autophagy.

Authors:  Lei Fu; Young-Ae Kim; Xuerong Wang; Xiaoyun Wu; Ping Yue; Sagar Lonial; Fadlo R Khuri; Shi-Yong Sun
Journal:  Cancer Res       Date:  2009-11-17       Impact factor: 12.701

10.  Fbw7 targets GATA3 through cyclin-dependent kinase 2-dependent proteolysis and contributes to regulation of T-cell development.

Authors:  Kyoko Kitagawa; Kiyoshi Shibata; Akinobu Matsumoto; Masaki Matsumoto; Tatsuya Ohhata; Keiichi I Nakayama; Hiroyuki Niida; Masatoshi Kitagawa
Journal:  Mol Cell Biol       Date:  2014-07       Impact factor: 4.272

View more
  15 in total

Review 1.  The GATA factor revolution in hematology.

Authors:  Koichi R Katsumura; Emery H Bresnick
Journal:  Blood       Date:  2017-02-08       Impact factor: 22.113

2.  CDK5/FBW7-dependent ubiquitination and degradation of EZH2 inhibits pancreatic cancer cell migration and invasion.

Authors:  Xin Jin; Chong Yang; Ping Fan; Jun Xiao; Wanli Zhang; Sudong Zhan; Tao Liu; Dejie Wang; Heshui Wu
Journal:  J Biol Chem       Date:  2017-02-27       Impact factor: 5.157

3.  SCF(Fbxo22)-KDM4A targets methylated p53 for degradation and regulates senescence.

Authors:  Yoshikazu Johmura; Jia Sun; Kyoko Kitagawa; Keiko Nakanishi; Toshiya Kuno; Aya Naiki-Ito; Yumi Sawada; Tomomi Miyamoto; Atsushi Okabe; Hiroyuki Aburatani; ShengFan Li; Ichiro Miyoshi; Satoru Takahashi; Masatoshi Kitagawa; Makoto Nakanishi
Journal:  Nat Commun       Date:  2016-02-12       Impact factor: 14.919

Review 4.  G-Protein Dependent Signal Transduction and Ubiquitination in Dictyostelium.

Authors:  Barbara Pergolizzi; Salvatore Bozzaro; Enrico Bracco
Journal:  Int J Mol Sci       Date:  2017-10-19       Impact factor: 5.923

5.  Pseudopodium-enriched atypical kinase 1 mediates angiogenesis by modulating GATA2-dependent VEGFR2 transcription.

Authors:  Huawei Wang; John Lapek; Ken Fujimura; Jan Strnadel; Bei Liu; David J Gonzalez; Wei Zhang; Felicia Watson; Vicky Yu; Chao Liu; Carina Muccilo Melo; Yury I Miller; Kathryn C Elliott; David A Cheresh; Richard L Klemke
Journal:  Cell Discov       Date:  2018-05-29       Impact factor: 10.849

6.  UV Damage-Induced Phosphorylation of HBO1 Triggers CRL4DDB2-Mediated Degradation To Regulate Cell Proliferation.

Authors:  Ryoichi Matsunuma; Hiroyuki Niida; Tatsuya Ohhata; Kyoko Kitagawa; Satoshi Sakai; Chiharu Uchida; Bunsyo Shiotani; Masaki Matsumoto; Keiichi I Nakayama; Hiroyuki Ogura; Norihiko Shiiya; Masatoshi Kitagawa
Journal:  Mol Cell Biol       Date:  2015-11-16       Impact factor: 4.272

Review 7.  Human GATA2 mutations and hematologic disease: how many paths to pathogenesis?

Authors:  Emery H Bresnick; Mabel M Jung; Koichi R Katsumura
Journal:  Blood Adv       Date:  2020-09-22

Review 8.  The emerging role of GATA transcription factors in development and disease.

Authors:  Marjolein H F M Lentjes; Hanneke E C Niessen; Yoshimitsu Akiyama; Adriaan P de Bruïne; Veerle Melotte; Manon van Engeland
Journal:  Expert Rev Mol Med       Date:  2016-03-08       Impact factor: 5.600

9.  The critical role of SENP1-mediated GATA2 deSUMOylation in promoting endothelial activation in graft arteriosclerosis.

Authors:  Cong Qiu; Yuewen Wang; Haige Zhao; Lingfeng Qin; Yanna Shi; Xiaolong Zhu; Lin Song; Xiaofei Zhou; Jian Chen; Hong Zhou; Haifeng Zhang; George Tellides; Wang Min; Luyang Yu
Journal:  Nat Commun       Date:  2017-06-01       Impact factor: 14.919

10.  PIASy antagonizes Ras-driven NSCLC survival by promoting GATA2 SUMOylation.

Authors:  Bin Chen; Jie Luo; Yirui Zhou; Xu Xin; Rong Cai; Chunhua Ling
Journal:  J Cancer       Date:  2018-04-18       Impact factor: 4.207

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.